Journal article
Depression motivates quit attempts but predicts relapse: differential findings for gender from the International Tobacco Control Study
J Cooper, R Borland, SA McKee, HH Yong, PA Dugué
Addiction Abingdon England | WILEY | Published : 2016
DOI: 10.1111/add.13290
Abstract
AIMS: To determine whether signs of current depression predict attempts to quit smoking, and short-term abstinence among those who try, and to test moderating effects of gender and cessation support (pharmacological and behavioural).DESIGN: Prospective cohort with approximately annual waves. Among smokers at one wave we assessed outcomes at the next wave using mixed-effects logistic regressions.SETTING: Waves 5-8 of the Four Country International Tobacco Control Study: a quasi-experimental cohort study of smokers from Canada, USA, UK and Australia.PARTICIPANTS: A total of 6811 tobacco smokers who participated in telephone surveys.MEASUREMENTS: Three-level depression index: (1) neither low po..
View full abstractRelated Projects (3)
Grants
Awarded by Office of Research on Women's Health
Funding Acknowledgements
We would like to thank members of the Data Management Core at the University of Waterloo for assistance in preparing the data for this analysis. We thank Mary Thompson for providing statistical advice. The ITC Four-Country Survey is supported by multiple grants including R01 CA 100362 and P50 CA111236 (Roswell Park Trans-disciplinary Tobacco Use Research Center) and also in part from grant P01 CA138389 (Roswell Park Cancer Institute, Buffalo, New York), all funded by the National Cancer Institute of the United States, Robert Wood Johnson Foundation (045734), Canadian Institutes of Health Research (57897, 79551), National Health and Medical Research Council of Australia (265903, 450110, APP1005922), Cancer Research UK (C312/A3726), Canadian Tobacco Control Research Initiative (014578); Centre for Behavioural Research and Program Evaluation, National Cancer Institute of Canada/Canadian Cancer Society. Sherry McKee receives grant money from the Office of Research on Women's Health, NIDA and the FDA's Office of Women's Health (P50 DA033945). Pierre-Antoine Dugue was financially supported by the NHMRC program grant number 1074383.